Literature DB >> 22801477

LKB1-AMPK axis revisited.

Filippos Kottakis1, Nabeel Bardeesy.   

Abstract

The LKB1 tumor suppressor encodes a serine-threonine kinase whose substrates control cell metabolism, polarity, and motility. LKB1 is a major mediator of the cellular response to energy stress via activation of the master regulator of energy homeostasis, AMPK. While mutational inactivation of LKB1 promotes the development of many types of epithelial cancer, a recent report in Nature by Jeon et al. demonstrates that the LKB1-AMPK pathway can also have an unexpected positive role in tumorigenesis, acting to maintain metabolic homeostasis and attenuate oxidative stress thereby supporting the survival of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801477      PMCID: PMC3515750          DOI: 10.1038/cr.2012.108

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  15 in total

Review 1.  Epithelial cell polarity, stem cells and cancer.

Authors:  Fernando Martin-Belmonte; Mirna Perez-Moreno
Journal:  Nat Rev Cancer       Date:  2011-12-15       Impact factor: 60.716

2.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

3.  5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

Authors:  Keith R Laderoute; Khalid Amin; Joy M Calaoagan; Merrill Knapp; Theresamai Le; Juan Orduna; Marc Foretz; Benoit Viollet
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress.

Authors:  Rishi Raj Chhipa; Yue Wu; James L Mohler; Clement Ip
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

5.  Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.

Authors:  J Carretero; P P Medina; R Blanco; L Smit; M Tang; G Roncador; L Maestre; E Conde; F Lopez-Rios; H C Clevers; M Sanchez-Cespedes
Journal:  Oncogene       Date:  2006-09-04       Impact factor: 9.867

6.  Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.

Authors:  Nabeel Bardeesy; Manisha Sinha; Aram F Hezel; Sabina Signoretti; Nathaniel A Hathaway; Norman E Sharpless; Massimo Loda; Daniel R Carrasco; Ronald A DePinho
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

7.  Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation.

Authors:  Kazuyoshi Kato; Tsutomu Ogura; Atsuhiro Kishimoto; Yuji Minegishi; Nobuyuki Nakajima; Masaru Miyazaki; Hiroyasu Esumi
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

Review 8.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

9.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.

Authors:  Reuben J Shaw; Monica Kosmatka; Nabeel Bardeesy; Rebecca L Hurley; Lee A Witters; Ronald A DePinho; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

10.  The ancient drug salicylate directly activates AMP-activated protein kinase.

Authors:  Simon A Hawley; Morgan D Fullerton; Fiona A Ross; Jonathan D Schertzer; Cyrille Chevtzoff; Katherine J Walker; Mark W Peggie; Darya Zibrova; Kevin A Green; Kirsty J Mustard; Bruce E Kemp; Kei Sakamoto; Gregory R Steinberg; D Grahame Hardie
Journal:  Science       Date:  2012-04-19       Impact factor: 47.728

View more
  14 in total

1.  Class III phosphatidylinositol-3-OH kinase controls epithelial integrity through endosomal LKB1 regulation.

Authors:  Fergal O'Farrell; Viola Hélène Lobert; Marte Sneeggen; Ashish Jain; Nadja Sandra Katheder; Eva Maria Wenzel; Sebastian Wolfgang Schultz; Kia Wee Tan; Andreas Brech; Harald Stenmark; Tor Erik Rusten
Journal:  Nat Cell Biol       Date:  2017-10-30       Impact factor: 28.824

2.  Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.

Authors:  Xinyuan Xu; Danwen Qian; Hongliang Liu; Diana Cruz; Sheng Luo; Kyle M Walsh; James L Abbruzzese; Xuefeng Zhang; Qingyi Wei
Journal:  Mol Carcinog       Date:  2019-04-17       Impact factor: 4.784

3.  In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.

Authors:  Qibiao Wu; Yahui Tian; Jian Zhang; Xinyuan Tong; Hsinyi Huang; Shuai Li; Hong Zhao; Ying Tang; Chongze Yuan; Kun Wang; Zhaoyuan Fang; Lei Gao; Xin Hu; Fuming Li; Zhen Qin; Shun Yao; Ting Chen; Haiquan Chen; Gong Zhang; Wanting Liu; Yihua Sun; Luonan Chen; Kwok-Kin Wong; Kai Ge; Liang Chen; Hongbin Ji
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205

4.  A Novel Phenylchromane Derivative Increases the Rate of Glucose Uptake in L6 Myotubes and Augments Insulin Secretion from Pancreatic Beta-Cells by Activating AMPK.

Authors:  Naomi Rozentul; Yosef Avrahami; Moran Shubely; Laura Levy; Anna Munder; Guy Cohen; Erol Cerasi; Shlomo Sasson; Arie Gruzman
Journal:  Pharm Res       Date:  2017-10-05       Impact factor: 4.200

5.  Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.

Authors:  Weidong Li; Baojin Hua; Shakir M Saud; Hongsheng Lin; Wei Hou; Matthias S Matter; Libin Jia; Nancy H Colburn; Matthew R Young
Journal:  Mol Carcinog       Date:  2014-05-17       Impact factor: 4.784

6.  The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.

Authors:  Ming Yan; Marie-Claude Gingras; Elaine A Dunlop; Yann Nouët; Fanny Dupuy; Zahra Jalali; Elite Possik; Barry J Coull; Dmitri Kharitidi; Anders Bondo Dydensborg; Brandon Faubert; Miriam Kamps; Sylvie Sabourin; Rachael S Preston; David Mark Davies; Taren Roughead; Laëtitia Chotard; Maurice A M van Steensel; Russell Jones; Andrew R Tee; Arnim Pause
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

7.  Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.

Authors:  Teresa Peart; Yudith Ramos Valdes; Rohann J M Correa; Elena Fazio; Monique Bertrand; Jacob McGee; Michel Préfontaine; Akira Sugimoto; Gabriel E DiMattia; Trevor G Shepherd
Journal:  Oncotarget       Date:  2015-09-08

8.  Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation.

Authors:  Mark Borris D Aldonza; Ji-Young Hong; Sang Kook Lee
Journal:  Exp Mol Med       Date:  2017-01-20       Impact factor: 8.718

9.  ATP increases within the lumen of the endoplasmic reticulum upon intracellular Ca2+ release.

Authors:  Neelanjan Vishnu; Muhammad Jadoon Khan; Felix Karsten; Lukas N Groschner; Markus Waldeck-Weiermair; Rene Rost; Seth Hallström; Hiromi Imamura; Wolfgang F Graier; Roland Malli
Journal:  Mol Biol Cell       Date:  2013-12-04       Impact factor: 3.612

10.  MicroRNA-661 modulates redox and metabolic homeostasis in colon cancer.

Authors:  Marta Gómez de Cedrón; Rebeca Acín Pérez; Ruth Sánchez-Martínez; Susana Molina; Jesús Herranz; Jaime Feliu; Guillermo Reglero; Jose Antonio Enríquez; Ana Ramírez de Molina
Journal:  Mol Oncol       Date:  2017-11-06       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.